


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.65%
+3.77%
+0.43%
+6.81%
0.00%
ADMA
ADMA Biologics
$17.31
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
ADMA Price Performance
$19.58 (-11.59%)
$15.25 (+13.51%)
$17.1 (+1.23%)
$16.9 (+2.43%)
ADMA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
ADMA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ADMA Street Sentiment is extremely bullish and have positive views on the near-term outlook
ADMA has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
What is ADMA current stock price?
What are ADMA stock strengths?
What is ADMA Risk Level?
What is ADMA market cap and volume?
What is ADMA current Stock IQ?
Should I buy ADMA stock right now?
Is ADMA a Strong Buy right now?
What does a 'Strong Buy' rating mean for ADMA?
What does a 'Strong Sell' rating mean for ADMA?
What factors influence ADMA's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.65%
+3.77%
+0.43%
+6.81%
0.00%
ADMA
ADMA Biologics
Current Price
$17.31
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market

ADMA Price Performance
$19.58 (-11.59%)
$15.25 (+13.51%)
$17.1 (+1.23%)
$16.9 (+2.43%)
ADMA Analysts Opinion
ADMA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
ADMA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ADMA Street Sentiment is extremely bullish and have positive views on the near-term outlook
ADMA has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
Nov 25, 2025
Upgrade
Buy
Zacks
ADMA Stock IQ
ADMA Latest Analysis
ADMA Biologics Reports Preliminary 2025 Results Ups 2026 Outlook . ADMA expects 2025 revenues of approximately $510-$511 million raising 2026 guidance on strong Asceniv demand and margin expansion.
Tue Jan 13, 2026
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?. The average brokerage recommendation (ABR) for Adma Biologics (ADMA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So is it worth buying the stock?
Tue Jan 13, 2026
ADMA Biologics Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.
Mon Jan 12, 2026
Why Adma Biologics (ADMA) Outpaced the Stock Market Today. In the most recent trading session Adma Biologics (ADMA) closed at $18.34 indicating a 1.72% shift from the previous trading day.
Tue Jan 6, 2026
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12 2026.
Mon Jan 5, 2026
ADMA Biologics Breaks Below 200-Day Moving Average - Notable for ADMA. In trading on Wednesday shares of ADMA Biologics Inc (Symbol: ADMA) crossed below their 200 day moving average of $18.20 changing hands as low as $18.17 per share. ADMA Biologics Inc shares are currently trading off about 0.7% on the day. The chart below shows the one year p
Wed Dec 31, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ADMA Stock trends
ADMA Stock performance
ADMA Stock analysis
ADMA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.